We are live on ! Find out more
NBP

NovaBridge Biosciences American Depositary Shares
NBP

Fund managers haven’t disclosed any holdings of NBP yet.

NBP Hedge Fund Activity: Q1 2026 in Review

48 of the 8,134 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2026, worth a combined $72.1M — down 45% from $132M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of NBP and 9 opened new positions — a net loss of 9 holders — while 15 trimmed existing stakes and 14 added.

The largest buyer was AIHC Capital Management, adding an estimated $6.19M. The largest seller was Janus Henderson Group, cutting an estimated $8.05M.

  • 48 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2026, down from 57 in Q4 2025.
  • Funds reported $72.1M of NovaBridge Biosciences American Depositary Shares stock for Q1 2026, down 45% quarter-over-quarter.
  • 9 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2026 and 18 closed out, a net change of -9 holders.
  • The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2026 was AIHC Capital Management, an estimated $6.19M added.
  • The largest NovaBridge Biosciences American Depositary Shares seller in Q1 2026 was Janus Henderson Group, an estimated $8.05M sold.

Based on aggregated 13F filings for Q1 2026.